[Prevention of post-surgical recurrence of Crohn's disease. A perspective].
Crohn's disease often leads to stricture formation, occlusion and surgery. Unfortunately the disease tends to recur often. Traditional medications seem very little effective for recurrence prevention. By contrast, biologics appear extremely promising and potentially capable of changing radically the management of this disease.
Paviotti
Alberto
A
Cattedre di Gastroenterologia, Chirurgia Digestiva, Anatomia Patologica e Radiologia, Università, Udine.
Terrosu
Giovanni
G
Avellini
Claudio
C
Girometti
Rossano
R
Sorrentino
Dario
D
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000517:prevention & control* / Q000601:surgery; D013505:Digestive System Surgical Procedures; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000069285:Infliximab; D016753:Interleukin-10 / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D055502:Secondary Prevention
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016753:Interleukin-10; D000069285:Infliximab